Integrated Financial Statements From 2010 to 2025
| IDGXF Stock | USD 0.68 0.02 2.86% |
Check Integrated Diagnostics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Integrated Diagnostics' main balance sheet or income statement drivers, such as , as well as many indicators such as . Integrated financial statements analysis is a perfect complement when working with Integrated Diagnostics Valuation or Volatility modules.
Integrated |
Integrated Diagnostics Holdings Company Profit Margin Analysis
Integrated Diagnostics' Profit Margin measures overall efficiency of a company and shows its ability to withstand competition as well as defend against adverse conditions such as rising costs, falling prices, decline in sales or management distress. Profit margin tells investors how well the company executes on its overall pricing strategies as well as how effective the company in controlling its costs.
Current Integrated Diagnostics Profit Margin | 0.17 % |
Most of Integrated Diagnostics' fundamental indicators, such as Profit Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Integrated Diagnostics Holdings is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, Profit Margin indicator shows the amount of money the company makes from total sales or revenue. It can provide a good insight into companies in the same sector, as well as help to identify trends of a company from year to year.
| Competition |
Based on the latest financial disclosure, Integrated Diagnostics Holdings has a Profit Margin of 0.1681%. This is 101.5% lower than that of the Healthcare sector and 101.45% lower than that of the Diagnostics & Research industry. The profit margin for all United States stocks is 113.24% lower than that of the firm.
Integrated Diagnostics Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Integrated Diagnostics's current stock value. Our valuation model uses many indicators to compare Integrated Diagnostics value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Integrated Diagnostics competition to find correlations between indicators driving Integrated Diagnostics's intrinsic value. More Info.Integrated Diagnostics Holdings is currently regarded as number one stock in return on equity category among its peers. It also is currently regarded as number one stock in return on asset category among its peers reporting about 0.46 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Integrated Diagnostics Holdings is roughly 2.18 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Integrated Diagnostics' earnings, one of the primary drivers of an investment's value.About Integrated Diagnostics Financial Statements
Integrated Diagnostics stakeholders use historical fundamental indicators, such as Integrated Diagnostics' revenue or net income, to determine how well the company is positioned to perform in the future. Although Integrated Diagnostics investors may analyze each financial statement separately, they are all interrelated. For example, changes in Integrated Diagnostics' assets and liabilities are reflected in the revenues and expenses on Integrated Diagnostics' income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Integrated Diagnostics Holdings. Please read more on our technical analysis and fundamental analysis pages.
Integrated Diagnostics Holdings plc, a consumer healthcare company, provides various medical diagnostics services to patients. The company was founded in 1979 and is headquartered in Saint Helier, Jersey. INTEGRATED DIAGNOSTICS is traded on OTC Exchange in the United States.
Currently Active Assets on Macroaxis
| DD | Dupont De Nemours | |
| CRDO | Credo Technology Group | |
| GOOG | Alphabet Inc Class C | |
| BAC | Bank of America | |
| CRM | Salesforce |
Other Information on Investing in Integrated Pink Sheet
Integrated Diagnostics financial ratios help investors to determine whether Integrated Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Integrated with respect to the benefits of owning Integrated Diagnostics security.